Subsidiary5 Aug 2026, 03:18 pm
Haleos Labs Subsidiary Appoints Cost Auditors and Nominee Director
AI Summary
Haleos Labs Ltd's material subsidiary, Mahi Drugs Private Limited, has appointed Annapragada & Co. as its Cost Auditors for the financial year 2026-27. Additionally, Mr. Vincent P. Asaro has been appointed as a Nominee Director, effective August 5, 2026, nominated by ChemWerth Inc. He replaces Mr. M. Madhu Rao. Mr. Asaro brings extensive experience in finance and pharmaceutical operations, currently serving as President of ChemWerth Inc. The appointments were approved at a Board meeting of the subsidiary held on August 5, 2026.
Key Highlights
- Subsidiary appoints cost auditors for FY 2026-27.
- New nominee director appointed, replacing previous director.
- Nominee director has significant experience in pharma and finance.
- Appointments made by subsidiary's Board of Directors.
Price Impact
More from HALEOSLABS